A new exchange-traded fund issued by VanEck has been tradable on Xetra and via the trading venue Börse Frankfurt since Wednesday.
The VanEck Bionic Engineering UCITS ETF offers exposure to companies in the bionics technology space. Bionics is a technical field concerned with the research and development of mechanical systems that closely mimic the functions or parts of living organisms.
Companies are considered that derive their income from medical, dental, and vision-related implants, bioprinting, prostheses or the preservation of organs and tissue. Producers of implantable and wearable devices or materials that are only used for cosmetic purposes are excluded.
The fund pursues a sustainable investment strategy.
|Name||Asset class||ISIN||On-going charges||Distribution policy||Reference index|
|VanEck Bionic Engineering UCITS ETF||Equity ETF||IE0005TF96I9||0.55 per cent||accumulating||MVIS Global Bionic Healthcare ESG Index|
The product offering in Deutsche Börse’s XTF segment currently comprises a total of 1,994 ETFs. With this selection and an average monthly trading volume of around €19 billion, Xetra is the leading trading venue for ETFs in Europe.